Characterizing the secretome of licensed hiPSC-derived MSCs

Although mesenchymal stromal cells (MSCs) from primary tissues have been successfully applied in the clinic, their expansion capabilities are limited and results are variable. MSCs derived from human-induced pluripotent stem cells (hiMSCs) are expected to overcome these limitations and serve as a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Yolande F. M., Tertel, Tobias, Shaw, Georgina, Staubach, Simon, de Almeida, Rodrigo Coutinho, Suchiman, Eka, Kuipers, Thomas B., Mei, Hailiang, Barry, Frank, Murphy, Mary, Giebel, Bernd, Meulenbelt, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438242/
https://www.ncbi.nlm.nih.gov/pubmed/36056373
http://dx.doi.org/10.1186/s13287-022-03117-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438242/
https://www.ncbi.nlm.nih.gov/pubmed/36056373
http://dx.doi.org/10.1186/s13287-022-03117-2

Ejemplares similares